BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26060394)

  • 1. Role of sodium tungstate as a potential antiplatelet agent.
    Fernández-Ruiz R; Pino M; Hurtado B; García de Frutos P; Caballo C; Escolar G; Gomis R; Diaz-Ricart M
    Drug Des Devel Ther; 2015; 9():2777-86. PubMed ID: 26060394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.
    Hosokawa K; Ohnishi T; Fukasawa M; Kondo T; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Microvasc Res; 2012 Mar; 83(2):154-61. PubMed ID: 22166857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.
    Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiplatelet activity of camel urine.
    Alhaidar A; Abdel Gader AG; Mousa SA
    J Altern Complement Med; 2011 Sep; 17(9):803-8. PubMed ID: 21854200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100® and Multiplate® whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo.
    Kim CW; Yun JW; Bae IH; Park YH; Jeong YS; Park JW; Chung JH; Park YH; Lim KM
    Thromb Res; 2011 Jun; 127(6):565-70. PubMed ID: 21420150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
    Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence.
    Tilly P; Charles AL; Ludwig S; Slimani F; Gross S; Meilhac O; Geny B; Stefansson K; Gurney ME; Fabre JE
    Cardiovasc Res; 2014 Mar; 101(3):482-91. PubMed ID: 24323317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antiplatelet activity of protocatechuic acid through the inhibition of high shear stress-induced platelet aggregation.
    Kim K; Bae ON; Lim KM; Noh JY; Kang S; Chung KY; Chung JH
    J Pharmacol Exp Ther; 2012 Dec; 343(3):704-11. PubMed ID: 22984226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
    Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
    Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
    Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
    Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets.
    Kuchay SM; Kim N; Grunz EA; Fay WP; Chishti AH
    Mol Cell Biol; 2007 Sep; 27(17):6038-52. PubMed ID: 17576811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
    Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
    Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
    Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus.
    Hu H; Zhu L; Huang Z; Ji Q; Chatterjee M; Zhang W; Li N
    Thromb Haemost; 2010 Dec; 104(6):1184-92. PubMed ID: 20838746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
    Coquerel D; Neviere R; Delile E; Mulder P; Marechal X; Montaigne D; Renet S; Remy-Jouet I; Gomez E; Henry JP; do Rego JC; Richard V; Tamion F
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1032-44. PubMed ID: 24578383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.